This editorial refers to the article ‘Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacy’ by Saskia R. Veldkamp et al. 2025; doi: 10.1093/rheumatology/keaf227
A fresh look at immunocytometry's role in personalized rheumatology
Valencic, EricaPrimo
;Tommasini, Alberto
Secondo
;Taddio, AndreaUltimo
2025-01-01
Abstract
This editorial refers to the article ‘Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacy’ by Saskia R. Veldkamp et al. 2025; doi: 10.1093/rheumatology/keaf227File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
keaf362.pdf
accesso aperto
Tipologia:
Documento in Versione Editoriale
Licenza:
Creative commons
Dimensione
373.53 kB
Formato
Adobe PDF
|
373.53 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
